12 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
or patients to get information on product safety, tolerability, immunogenicity, pharmacological activity, or pharmacokinetics, as more fully defined in 21
424B4
nc8gs3b
5 Oct 20
Prospectus supplement with pricing info
4:16pm
- Prev
- 1
- Next